Skip to main content
Journal cover image

Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?

Publication ,  Journal Article
Wolf, M
Published in: Semin Dial
2011

Duke Scholars

Published In

Semin Dial

DOI

EISSN

1525-139X

Publication Date

2011

Volume

24

Issue

4

Start / End Page

428 / 430

Location

United States

Related Subject Headings

  • Vitamins
  • Vitamin D
  • Urology & Nephrology
  • Parathyroid Hormone
  • Kidney Failure, Chronic
  • Humans
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wolf, M. (2011). Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Semin Dial, 24(4), 428–430. https://doi.org/10.1111/j.1525-139X.2011.00914.x
Wolf, Myles. “Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?Semin Dial 24, no. 4 (2011): 428–30. https://doi.org/10.1111/j.1525-139X.2011.00914.x.
Wolf, Myles. “Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?Semin Dial, vol. 24, no. 4, 2011, pp. 428–30. Pubmed, doi:10.1111/j.1525-139X.2011.00914.x.
Journal cover image

Published In

Semin Dial

DOI

EISSN

1525-139X

Publication Date

2011

Volume

24

Issue

4

Start / End Page

428 / 430

Location

United States

Related Subject Headings

  • Vitamins
  • Vitamin D
  • Urology & Nephrology
  • Parathyroid Hormone
  • Kidney Failure, Chronic
  • Humans
  • 3202 Clinical sciences
  • 1103 Clinical Sciences